Scholar Rock Holding Corp (SRRK)
Data as of , from SEC Form 4 filings.
See up to 3 months of SRRK. The 7-day demo opens the 1M and 3M ranges and puts SRRK on your watchlist.
Start 7-day demoLatest SRRK insider trades
About Scholar Rock Holding Corp (SRRK)
Scholar Rock Holding Corp files with the SEC under CIK 0001727196 and is classified as biological products (no diagnostic substances). We track it alongside the rest of the Health Care sector.
SRRK Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 6 | 289,470 | $12.00M |
| Bona-fide gift | 2 | 84,686 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
SRRK insider transactions (Form 4)
8367 Form 4 filings on record, the earliest from Oct 7, 2024, newest first. Filing history page 2 of 3.
| Traded | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Grant or award | Common Stock | 128,004 footnote F1 | $0.00 | - | ||
| ||||||
| Keith Woods - Officer | Grant or award | Common Stock | 47,021 footnote F1 | $0.00 | - | |
| ||||||
| Invus Global Management, LLC | Other | Common Stock | 1,575,008 | $7.35 | $11.58M | |
| Invus Global Management, LLC | Other | Warrant (right to buy) | 1,575,008 | $0.00 | - | |
| Mo Qatanani - Officer | Open-market sale | Common Stock | 2,119 footnote F1 | $45.87 footnote F2 | $97K | |
| Mo Qatanani - Officer | Open-market sale | Common Stock | 12,779 footnote F1 | $46.85 footnote F4 | $599K | |
| ||||||
| Mo Qatanani - Officer | Open-market sale | Common Stock | 8,406 footnote F1 | $44.48 | $374K | |
| ||||||
| Caryn Parlavecchio - Officer | Open-market sale | Common Stock | 6,600 footnote F1 | $44.48 | $294K | |
| ||||||
| Jing L. Marantz - Officer | Open-market sale | Common Stock | 5,798 footnote F1 | $44.48 | $258K | |
| ||||||
| Junlin Ho - Officer | Open-market sale | Common Stock | 8,016 footnote F1 | $44.48 | $357K | |
| ||||||
| Mo Qatanani - Officer | Option exercise | Common Stock | 1,407 footnote F1 | $18.08 | $25K | |
| Mo Qatanani - Officer | Option exercise | Common Stock | 321 footnote F1 | $7.62 | $2K | |
| Mo Qatanani - Officer | Option exercise | Common Stock | 2,813 footnote F1 | $10.00 | $28K | |
| Mo Qatanani - Officer | Option exercise | Common Stock | 5,893 footnote F1 | $15.75 | $93K | |
| Mo Qatanani - Officer | Option exercise | Common Stock | 2,678 footnote F1 | $35.15 | $94K | |
| Mo Qatanani - Officer | Open-market sale | Common Stock | 13,112 footnote F1 | $45.20 footnote F7 | $593K | |
| Mo Qatanani - Officer | Option exercise | Stock Option (Right to Buy) | 1,407 | $0.00 | - | |
| Mo Qatanani - Officer | Option exercise | Stock Option (Right to Buy) | 321 | $0.00 | - | |
| Mo Qatanani - Officer | Option exercise | Stock Option (Right to Buy) | 2,813 | $0.00 | - | |
| Mo Qatanani - Officer | Option exercise | Stock Option (Right to Buy) | 5,893 | $0.00 | - | |
| Mo Qatanani - Officer | Option exercise | Stock Option (Right to Buy) | 2,678 | $0.00 | - | |
| ||||||
| Open-market sale | Common Stock | 16,755 footnote F1,F2 | $42.70 | $715K | ||
| ||||||
| Keith Woods - Officer | Open-market sale | Common Stock | 16,746 footnote F1,F2 | $42.70 | $715K | |
| ||||||
| Open-market sale | Common Stock | 20,438 footnote F1,F2 | $42.70 | $873K | ||
| ||||||
| Open-market sale | Common Stock | 57,450 footnote F1,F2 | $42.70 | $2.45M | ||
| ||||||
| Open-market purchase | Common Stock | 12,796 | $39.31 footnote F1 | $503K | ||
| Open-market purchase | Common Stock | 12,400 | $40.18 footnote F3 | $498K | ||
| Open-market purchase | Common Stock | 4,403 | $40.97 footnote F4 | $180K | ||
| Other | Common Stock | 1,064,804 | $7.35 | $7.83M | ||
| Other | Warrants to Purchase Common Stock | 1,064,804 | $0.00 | - | ||
| ||||||
| Mo Qatanani - Officer | Option exercise | Common Stock | 65,625 footnote F1 | $26.05 | $1.71M | |
| Mo Qatanani - Officer | Option exercise | Common Stock | 21,093 footnote F1 | $18.08 | $381K | |
| Mo Qatanani - Officer | Option exercise | Common Stock | 5,607 footnote F1 | $4.86 | $27K | |
| Mo Qatanani - Officer | Option exercise | Common Stock | 1,281 footnote F1 | $7.62 | $10K | |
| Mo Qatanani - Officer | Option exercise | Common Stock | 11,250 footnote F1 | $10.00 | $113K | |
| Mo Qatanani - Officer | Option exercise | Common Stock | 23,571 footnote F1 | $15.75 | $371K | |
| Mo Qatanani - Officer | Option exercise | Common Stock | 8,035 footnote F1 | $35.15 | $282K | |
| Mo Qatanani - Officer | Open-market sale | Common Stock | 136,462 footnote F1 | $45.21 footnote F9 | $6.17M | |
| Mo Qatanani - Officer | Option exercise | Stock Option (Right to Buy) | 65,625 | $0.00 | - | |
| Mo Qatanani - Officer | Option exercise | Stock Option (Right to Buy) | 21,093 | $0.00 | - | |
| Mo Qatanani - Officer | Option exercise | Stock Option (Right to Buy) | 5,607 | $0.00 | - | |
| Mo Qatanani - Officer | Option exercise | Stock Option (Right to Buy) | 1,281 | $0.00 | - | |
| Mo Qatanani - Officer | Option exercise | Stock Option (Right to Buy) | 11,250 | $0.00 | - | |
| Mo Qatanani - Officer | Option exercise | Stock Option (Right to Buy) | 23,571 | $0.00 | - | |
| Mo Qatanani - Officer | Option exercise | Stock Option (Right to Buy) | 8,035 | $0.00 | - | |
| ||||||
| Open-market purchase | Common Stock | 11,011 | $35.61 footnote F1 | $392K | ||
| Open-market purchase | Common Stock | 56,703 | $36.74 footnote F3 | $2.08M | ||
| Open-market purchase | Common Stock | 319,700 | $37.42 footnote F4 | $11.96M | ||
| Open-market purchase | Common Stock | 18,414 | $37.89 footnote F5 | $698K | ||
| Open-market purchase | Common Stock | 80,863 | $38.68 footnote F6 | $3.13M | ||
| Open-market purchase | Common Stock | 13,748 | $39.52 footnote F7 | $543K | ||
| ||||||
| Gift | Common Stock | 205,000 | $0.00 | - | ||
| Mo Qatanani - Officer | Open-market sale | Common Stock | 3,353 | $30.67 | $103K | |
| Mo Qatanani - Officer | Open-market sale | Common Stock | 3,178 | $33.52 | $107K | |
| Katie Peng | Open-market sale | Common Stock | 930 | $32.48 | $30K | |
| Katie Peng | Open-market sale | Common Stock | 76 | $33.20 | $3K | |
| Caryn Parlavecchio - Officer | Open-market sale | Common Stock | 2,178 | $31.17 | $68K | |
| Jeffrey S. Flier | Open-market sale | Common Stock | 11,136 | $40.02 | $446K | |
| Mo Qatanani - Officer | Open-market sale | Common Stock | 24,066 | $34.44 | $829K | |
| Michael Gilman | Open-market sale | Common Stock | 630 | $29.22 | $18K | |
| Michael Gilman | Open-market sale | Common Stock | 2,745 | $29.83 | $82K | |
| Michael Gilman - Director | Grant or award | Common Stock | 7,632 | $0.00 | - | |
| Michael Gilman - Director | Grant or award | Stock Option (Right to Buy) | 9,206 | $0.00 | - | |
| Grant or award | Common Stock | 7,632 | $0.00 | - | ||
| Grant or award | Stock Option (Right to Buy) | 9,206 | $0.00 | - | ||
| Invus Public Equities, L.P. | Open-market sale | Common Stock | 1,600,000 | $41.65 | $66.64M | |
| Invus Public Equities, L.P. | Open-market sale | Common Stock | 208,272 | $37.63 | $7.84M | |
| Invus Public Equities, L.P. | Open-market sale | Common Stock | 43,887 | $38.43 | $1.69M | |
| Invus Public Equities, L.P. | Open-market sale | Common Stock | 126,442 | $39.51 | $5.00M | |
| Invus Public Equities, L.P. | Open-market sale | Common Stock | 30,683 | $40.14 | $1.23M | |
| Invus Public Equities, L.P. | Open-market sale | Common Stock | 149 | $40.98 | $6K | |
| Jing L. Marantz - Officer | Option exercise | Common Stock | 2,145 | $8.59 | $18K | |
| Jing L. Marantz - Officer | Open-market sale | Common Stock | 2,145 | $30.01 | $64K | |
| Jing L. Marantz - Officer | Option exercise | Common Stock | 6,375 | $8.59 | $55K | |
| Jing L. Marantz - Officer | Open-market sale | Common Stock | 1,000 | $38.04 | $38K | |
| Jing L. Marantz - Officer | Open-market sale | Common Stock | 2,100 | $39.25 | $82K | |
| Jing L. Marantz - Officer | Open-market sale | Common Stock | 3,075 | $39.93 | $123K | |
| Jing L. Marantz - Officer | Open-market sale | Common Stock | 200 | $40.72 | $8K | |
| Jing L. Marantz - Officer | Option exercise | Stock Option (Right to Buy) | 2,145 | $0.00 | - | |
| Jing L. Marantz - Officer | Option exercise | Stock Option (Right to Buy) | 6,375 | $0.00 | - | |
| Jing L. Marantz - Officer | Option exercise | Common Stock | 2,105 | $8.59 | $18K | |
| Jing L. Marantz - Officer | Open-market sale | Common Stock | 2,105 | $30.00 | $63K | |
| Jing L. Marantz - Officer | Option exercise | Stock Option (Right to Buy) | 2,105 | $0.00 | - | |
Recent SRRK Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Katie Peng | Director | 1,006 | $49K | View on EDGAR | |
| - | - | - |
SRRK insider trading FAQ
What is the latest insider trade for SRRK?
Scholar Rock Holding Corp (SRRK) had 3 insider filings in the last 90 days, with the most recent on 27 October 2026. The full record for SRRK runs to 67 Form 4 filings, the earliest from 7 October 2024. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying SRRK stock?
6 insider purchases of SRRK were filed in the last 90 days, totaling $12.00M.
How many insiders are selling SRRK stock?
No insider sales of SRRK were filed in the last 90 days. 70 sales are on record for this company.
Where can I see SRRK SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects SRRK Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Srinivas Akkaraju view on EDGAR
- - Keith Woods view on EDGAR
- - David Hallal view on EDGAR
- - Jeffrey S. Flier view on EDGAR
- - Michael Gilman view on EDGAR
- - Kristina Burow view on EDGAR
- - Joshua Reed view on EDGAR
- - Katie Peng view on EDGAR
- - Jeffrey S. Flier view on EDGAR
Related companies with recent insider activity
Learn more
- How to read insider buying signals
- What an open-market purchase by an insider can and cannot tell you.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where SRRK's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow SRRK with a 7-day demo
- SRRK on your watchlist
- Every SRRK Form 4 filing on record
- Up to 3 months of SRRK price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive